Back to Search
ADNAN RAZA, M.D.
M.D.
Clinical Cardiac Electrophysiology Physician
NPI: 1124414479IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Critical Care Medicine
Code: 207RC0200X
296852(NY)
Internal Medicine — Clinical Cardiac Electrophysiology
Code: 207RC0001X
A198227(CA)
CMS Specialties
PrimaryCARDIAC ELECTROPHYSIOLOGY
Education
OTHER
Class of 2015
Research & Publications (20)
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome.
PMID 19439093·J Hematol Oncol·2009
3-trial
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial.
PMID 19557623·Leuk Lymphoma·2009
3-trial
Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome.
PMID 19398716·Blood·2009
3-trial
Characterization of a novel dithiocarbamate glutathione reductase inhibitor and its use as a tool to modulate intracellular glutathione.
PMID 19049979·J Biol Chem·2009
8-other
Design and synthesis of sulfoximine based inhibitors for HIV-1 protease.
PMID 18829317·Bioorg Med Chem Lett·2008
8-other
Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia.
PMID 18720364·Cancer·2008
8-other
Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.
PMID 17893227·Blood·2008
3-trial
Development and application of spectrophotometric methods for the determination of citalopram hydrobromide in dosage forms.
PMID 16595940·Chem Pharm Bull (Tokyo)·2006
8-other
Phase II study of topotecan and thalidomide in patients with high-risk myelodysplastic syndromes.
PMID 16396766·Leuk Lymphoma·2006
3-trial
Remicade as TNF suppressor in patients with myelodysplastic syndromes.
PMID 15370256·Leuk Lymphoma·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 315 S MANNING BLVD
ALBANY, NY 12208 - Phone
- (518) 525-1703
Quick Facts
- NPI
- 1124414479
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile